ProfileGDS4718 / 202225_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 96% 96% 95% 95% 96% 91% 91% 96% 96% 96% 95% 96% 95% 92% 93% 95% 95% 91% 94% 90% 96% 95% 96% 96% 95% 92% 95% 92% 97% 89% 91% 91% 96% 97% 91% 92% 91% 95% 96% 95% 96% 88% 93% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.804396
GSM549102patient 115, normal, homogenized [OPG study]10.671796
GSM549104patient 119, normal, homogenized [OPG study]10.336195
GSM549108patient 138, normal, homogenized [OPG study]10.325495
GSM549119patient 077, normal, homogenized [OPG study]10.584996
GSM549133patient 032, cancer, homogenized [OPG study]9.3904991
GSM549139patient 042, cancer, homogenized [OPG study]9.3876191
GSM549099patient 107, normal, homogenized [OPG study]10.580196
GSM549109patient 139, normal, homogenized [OPG study]10.564396
GSM549110patient 046, normal, homogenized [OPG study]10.579996
GSM549114patient 063, normal, homogenized [OPG study]10.57195
GSM549122patient 082, normal, homogenized [OPG study]10.518196
GSM549134patient 033, cancer, homogenized [OPG study]10.26395
GSM549136patient 036, cancer, homogenized [OPG study]9.5344292
GSM549140patient 044, cancer, homogenized [OPG study]9.6749993
GSM549111patient 047, normal, homogenized [OPG study]10.253295
GSM549113patient 057, normal, homogenized [OPG study]10.57595
GSM549132patient 031, cancer, homogenized [OPG study]9.3577291
GSM549137patient 038, cancer, homogenized [OPG study]9.8778794
GSM549142patient 047, cancer, homogenized [OPG study]8.6748790
GSM549100patient 110, normal, homogenized [OPG study]10.52696
GSM549107patient 135, normal, homogenized [OPG study]10.452595
GSM549115patient 068, normal, homogenized [OPG study]10.663696
GSM549116patient 072, normal, homogenized [OPG study]10.55296
GSM549120patient 078, normal, homogenized [OPG study]10.303795
GSM549131patient 030, cancer, homogenized [OPG study]9.6552392
GSM549118patient 074, normal, homogenized [OPG study]10.419195
GSM549129patient 027, cancer, homogenized [OPG study]9.3742692
GSM549123patient 088, normal, homogenized [OPG study]10.848397
GSM549124patient 006, cancer, homogenized [OPG study]8.9128189
GSM549126patient 015, cancer, homogenized [OPG study]9.3613591
GSM549128patient 025, cancer, homogenized [OPG study]9.2818691
GSM549103patient 117, normal, homogenized [OPG study]10.614896
GSM549117patient 073, normal, homogenized [OPG study]11.06497
GSM549138patient 041, cancer, homogenized [OPG study]9.34991
GSM549141patient 045, cancer, homogenized [OPG study]9.5426892
GSM549130patient 028, cancer, homogenized [OPG study]9.1926591
GSM549101patient 111, normal, homogenized [OPG study]10.28195
GSM549105patient 128, normal, homogenized [OPG study]10.403196
GSM549106patient 134, normal, homogenized [OPG study]10.324695
GSM549112patient 048, normal, homogenized [OPG study]10.693496
GSM549125patient 011, cancer, homogenized [OPG study]8.8071988
GSM549127patient 024, cancer, homogenized [OPG study]9.5464393
GSM549135patient 035, cancer, homogenized [OPG study]9.7388293